| Dr Yuri Zermeno, MD | |
|
100 Spalding Dr Ste 406, Naperville, IL 60540-6554 | |
| (630) 961-9485 | |
| (630) 961-9578 |
| Full Name | Dr Yuri Zermeno |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 100 Spalding Dr Ste 406, Naperville, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003310186 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 036.159147 (Illinois) | Primary |
| Entity Name | Edward Health Ventures |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962452912 PECOS PAC ID: 4284531484 Enrollment ID: O20031216000616 |
News Archive
Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that it would implement an 8-for-1 reverse split of its issued and outstanding common shares, effective for shareholders of record on February 1, 2010, and a proportional reduction of its authorized common and preferred shares.
More than three-quarters (76%) of Italian adolescents who completed anonymous questionnaires consumed caffeine on a daily basis and nearly half (46%) exceeded the upper limits recommended by the American Academy of Pediatrics.
Research led by Ashok Aiyar, PhD, Associate Professor of Microbiology at LSU Health Sciences Center New Orleans, showing that a single gene can control growth in cancers related to the Epstein-Barr virus and that existing therapeutics can inactivate it, will be published in the June 12, 2009 online issue of PLoS Pathogens.
Cancer cells often devise ways to survive even in the presence of toxic chemotherapy. Now, a research team led by investigators at Beth Israel Deaconess Medical Center has found a way to attack a process that tumor cells use to escape the effects of standard cancer drugs. The discovery is published online today in the journal Nature Cell Biology.
› Verified 5 days ago
| Entity Name | Riverside Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417061193 PECOS PAC ID: 3274434717 Enrollment ID: O20040116000780 |
News Archive
Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that it would implement an 8-for-1 reverse split of its issued and outstanding common shares, effective for shareholders of record on February 1, 2010, and a proportional reduction of its authorized common and preferred shares.
More than three-quarters (76%) of Italian adolescents who completed anonymous questionnaires consumed caffeine on a daily basis and nearly half (46%) exceeded the upper limits recommended by the American Academy of Pediatrics.
Research led by Ashok Aiyar, PhD, Associate Professor of Microbiology at LSU Health Sciences Center New Orleans, showing that a single gene can control growth in cancers related to the Epstein-Barr virus and that existing therapeutics can inactivate it, will be published in the June 12, 2009 online issue of PLoS Pathogens.
Cancer cells often devise ways to survive even in the presence of toxic chemotherapy. Now, a research team led by investigators at Beth Israel Deaconess Medical Center has found a way to attack a process that tumor cells use to escape the effects of standard cancer drugs. The discovery is published online today in the journal Nature Cell Biology.
› Verified 5 days ago
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that it would implement an 8-for-1 reverse split of its issued and outstanding common shares, effective for shareholders of record on February 1, 2010, and a proportional reduction of its authorized common and preferred shares.
More than three-quarters (76%) of Italian adolescents who completed anonymous questionnaires consumed caffeine on a daily basis and nearly half (46%) exceeded the upper limits recommended by the American Academy of Pediatrics.
Research led by Ashok Aiyar, PhD, Associate Professor of Microbiology at LSU Health Sciences Center New Orleans, showing that a single gene can control growth in cancers related to the Epstein-Barr virus and that existing therapeutics can inactivate it, will be published in the June 12, 2009 online issue of PLoS Pathogens.
Cancer cells often devise ways to survive even in the presence of toxic chemotherapy. Now, a research team led by investigators at Beth Israel Deaconess Medical Center has found a way to attack a process that tumor cells use to escape the effects of standard cancer drugs. The discovery is published online today in the journal Nature Cell Biology.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yuri Zermeno, MD 100 Spalding Dr Ste 406, Naperville, IL 60540-6554 Ph: (630) 961-9485 | Dr Yuri Zermeno, MD 100 Spalding Dr Ste 406, Naperville, IL 60540-6554 Ph: (630) 961-9485 |
News Archive
Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that it would implement an 8-for-1 reverse split of its issued and outstanding common shares, effective for shareholders of record on February 1, 2010, and a proportional reduction of its authorized common and preferred shares.
More than three-quarters (76%) of Italian adolescents who completed anonymous questionnaires consumed caffeine on a daily basis and nearly half (46%) exceeded the upper limits recommended by the American Academy of Pediatrics.
Research led by Ashok Aiyar, PhD, Associate Professor of Microbiology at LSU Health Sciences Center New Orleans, showing that a single gene can control growth in cancers related to the Epstein-Barr virus and that existing therapeutics can inactivate it, will be published in the June 12, 2009 online issue of PLoS Pathogens.
Cancer cells often devise ways to survive even in the presence of toxic chemotherapy. Now, a research team led by investigators at Beth Israel Deaconess Medical Center has found a way to attack a process that tumor cells use to escape the effects of standard cancer drugs. The discovery is published online today in the journal Nature Cell Biology.
› Verified 5 days ago
Dr. Michael T Feingold, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 640 S Washington St, Ste 220, Naperville, IL 60540 Phone: 630-428-1500 Fax: 630-428-3544 | |
Dr. Elena Pirozhnik, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10 W Martin Ave # 100, Naperville, IL 60540 Phone: 630-369-7700 Fax: 630-369-7705 | |
Dr. Melissa May Deer Pelletier, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 636 Raymond Dr Ste 303, Naperville, IL 60563 Phone: 630-653-4240 Fax: 630-315-1505 | |
Dr. Andrew K. Badowski, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 10 W Martin Ave # 100, Naperville, IL 60540 Phone: 630-369-7700 Fax: 630-369-7705 | |
Dr. Charles Edward Miller, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 120 Osler Drive, Suite 100, Naperville, IL 60540 Phone: 630-428-2229 Fax: 630-428-0336 | |
Meghan M Flannery, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 720 Brom Ct, S-104, Naperville, IL 60540 Phone: 630-717-9977 Fax: 630-717-6267 |